跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
i-Thymus
首页
药物
i-Thymus
i-Thymus
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
METHOD FOR REDUCING OR ELIMINATING ALLOGRAFT REJECTION BY USING THYMUS VACCINE
申请人: UNIV TONGJI
优先权: 2024
CN
WO
2 件公开
Application of epimedium flavonoid glycoside compound in preparation of medicine for treating melanoma
申请人: GOLDEN HEALTH FOSHAN TECH CO LTD
优先权: 2020
CN
NOVEL APIARY COMPOSITION
申请人: CHEMOR KUTATO FEJLESZTO ES KER
优先权: 2007
EP
WO
2 件公开
Lactobacillus mucilaginosus HFY202414 and application of lactobacillus mucilaginosus HFY202414 in repairing immune impairment
申请人: CHONGQING PAIBAILE BIOTECHNOLOGY CO LTD
优先权: 2024
CN
Application of polyethylene glycol artesunate in preparation of anti-pulmonary fibrosis medicine
申请人: KPC PHARMACEUTICALS INC
优先权: 2016
CN
Immunoregulatory factor as well as preparation method and application thereof
申请人: GUANGZHOU HEYING BIOLOGICAL TECH CO LTD
优先权: 2026
CN
Swine fever oral attenuated freezing-dry vaccine and preparation method thereof and freeze-drying protective agent
申请人: SHANGHAI ACAD AGRI SCIENCES
优先权: 2015
CN
Application of BET protein inhibitor in preparation of chronic graft versus host disease medicine
申请人: UNIV SUZHOU
优先权: 2021
CN
药物
反馈